4//SEC Filing
Higgins Jack 4
Accession 0001209191-23-057567
CIK 0001472012other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:08 PM ET
Size
5.9 KB
Accession
0001209191-23-057567
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Higgins Jack
Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2023-12-01+200,000→ 200,000 totalExercise: $7.80Exp: 2033-11-30→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]On December 1, 2023, Dr. Higgins was granted an option to purchase 200,000 shares of common stock. The option vests (i) with respect to 100,000 shares, 25% of such shares subject to the option, vest on November 17, 2024, and the remaining shares will vest monthly thereafter over three years, and (ii) with respect to the remaining 100,000 shares, which vesting shall commence as of the date a certain condition set forth in Dr. Higgins' Amended and Restated Offer Letter dated November 30, 2023, is satisfied, 25% of the shares subject to the option will vest 1 year from the completion of that certain condition, and the remaining shares will vest monthly thereafter over three years.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001993684
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 9:08 PM ET
- Size
- 5.9 KB